MIT Horizon, Dyno Therapeutics: Machine Learning for Advancing Gene Therapy and Genome Editing

Register for Webinar >>

About webinar

Eric Kelsic (CEO, Founder) and Sam Sinai (Co-founder, Lead Machine Learning Scientist) from Dyno Therapeutics are joining us to share their machine learning solution for advancing gene therapy and genome editing. We'll do a deep dive into Adeno-associated virus (AAV) delivery of these therapies. In the remainder of the event, you'll get the opportunity to ask live questions of the pair.

Speakers

  Eric Kelsic
  PhD, Cofounder & CEO of Dyno

  Sam Sinai
  PhD, Cofounder & Lead ML Scientist of Dyno